Diabetes Research

GLP-1 is a peptide proven to be an effective treatment for diabetes and weight management. However, taking any peptide that has not been approved as a medication is risky and potentially ineffective.

Managing diabetes at work can mean balancing deadlines, meetings, glucose checks, and treatment while also dealing with comments from coworkers who don’t understand. Advocates and people with diabetes discuss how to respond – and why preventing stigma should not fall on people with diabetes alone.

Tzield has been shown to delay the onset of type 1 diabetes by an average of two years. Here’s more about screening and whether treatment may be right for you.

At the American Diabetes Association's 2026 Scientific Sessions in New Orleans, tech updates were focused on making diabetes care more accessible and less disruptive.

People with type 1 diabetes are making insulin again through experimental and FDA-approved treatments. What challenges remain in order to make these transplants safe and widely accessible?

Big new insights on diabetes treatments and technology emerged from the American Diabetes Association’s (ADA) 2026 conference in New Orleans. Here’s what matters most for people living with diabetes.